This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
T. P. Cooley , L. M. Kunches , C. A. Saunders , J. K. Ritter , C. J. Perkins , C. McLaren , R. P. McCaffrey & H. A. Liebman (1990b). Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. New England Journal of Medicine 322, 1340–5.
J. A. Englund , M. E. Zimmerman , E. M. Swierkosz , J. L. Goodman , D. R. Scholl & H. H. J. Balfour (1990). Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Annals of Internal Medicine 112, 416–22.
L. M. Evans , L. M. Itri , M. Campion , P. R. Wyler , S. E. Krown , J. E. Groopman , H. Goldswieg , P. A. Volberding , S. B. West & R. T. Mitsuyasu (1991). Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Journal of Immunotherapy 10, 39–50.
A. S. Fauci , S. M. Schnittman , G. Poli , S. Koenig & G. Pantaleo (1991). NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Annals of Internal Medicine 114, 678–93.
H. E. Gendelman , J. M. Orenstein , M. A. Martin , C. Ferrua , R. Mitra , T. Phipps , L. A. Wahl , H. C. Lane , A. S. Fauci & D. S. Burke (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. Journal of Experimental Medicine 167, 1428–41..
W. Heagy , C. Crumpacker , P. A. Lopez & R. W. Finberg (1991). Inhibition of immune functions by antiviral drugs. Journal of Clinical Investigation 87, 1916–24.
E. Joly ., L. Mucke & M. B. Oldstone (1991). Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253, 1283–5.
J. O. Kahn , S. Lagakos , D. Richman , A. Cross , C. Pettinelli , S.-H. Liou , M. Brown , P. Volberding , C. Crumpacker , G. Beall , H. Sacks , T. C. Merigan , M. Beltangady , L. Smaldone , R. Dolin & The National Aids Clinical Trials Group (1992). A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. New England Journal of Medicine 327, 581–7.
B. A. Larder , G. Darby & D. D. Richman (1989). HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731–4.
R. D. Moore , J. Keruly , D. D. Richman , K. T. Creagh & R. E. Chaisson (1992). Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group. AIDS 6, 671–7.
T. Moriyama , S. Guilhot , K. Klopchin , B. Moss , C. Pinkert , R. Palmiter , R. Brinster , O. Kanagawa & F. Chisari (1990). Immunobiology and pathogenesis of hepatocellular injury in transgenic mice. Science 248, 361–4.
A. G. Morris , Y. L. Lin & B. A. Askonas (1982). Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature 295, 150–2.
B. F. Polk , R. Fox , R. Brookmeyer , S. Kancharnaraksa , R. Kaslow , B. Visscher , C. Rinaldo & J. Phair (1987). Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. New England Journal of Medicine 316, 61–6.
G. V. J. Quinnan , N. Kirmani , A. H. Rook , J. F. Manischewitz , L. Jackson , G. Moreschi , G. W. Santos , R. Saral & W. H. Burns (1982). Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-Iymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. New England Journal of Medicine 307, 7–13.
M. H. st Clair , J. L. Martin , W. G. Tudor , M. C. Bach , C. L. Vavro , D. M. King , P. Kellam , S. D. Kemp & B. A. Larder (1991). Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253, 1557–9.
P. A. Volberding , S. W. Lagakos , M. A. Koch , C. Pettinelli , M. W. Myers , D. K. Booth , H. H. J. Balfour , R. C. Reichman , J. A. Bartlett & M. S. Hirsch (1990). Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine 322, 941–9.
R. J. Whitley , C. A. Alford , M. S. Hirsch , R. T. Schooley , J. P. Luby , F. Y. Aoki , D. Hanley , A. J. Nahmias & S. J. Soong (1986). Vidarabine versus acyclovir therapy in herpes simplex encephalitis. New England Journal of Medicine 314, 144–9.
K. L. Yap , G. L. Ada & I. F. McKenzie (1978). Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 273, 238–9.
R. Yarchoan , D. J. Venzon , J. M. Pluda , J. Lietzau , K. M. Wyvill , A. A. Tsiatis , S. M. Steinberg & S. Broder (1991). CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Annals of Internal Medicine 115, 184–9.